SARA mutant mice had decreased levels of Smad2 protein in skin tissue and exhibited a similar tumorigenic phenotype as keratinocyte-specific Smad2-KO mice, indicating that SARA may exert its tumor suppressive effects in part through modulation of Smad2 protein levels. The gene discussed is SAR1A; the disease is neoplasm.